STOCK TITAN
  1. Home
  2. Sec-filings
  3. GEHC
  4. [Form 4] GE HealthCare Technologies Inc. Insider Trading Activity

GE HealthCare (GEHC) grants 777 restricted stock units to director Kevin Lobo

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Lobo Kevin reported acquisition or exercise transactions in this Form 4 filing.

GE HealthCare Technologies Inc. director Kevin Lobo received an equity award of 777 restricted stock units of common stock. These RSUs were granted at no cash cost to him and represent compensation rather than an open-market purchase or sale.

According to the award terms, 100% of the 777 restricted stock units will vest on the earlier of GE HealthCare’s next annual meeting of stockholders or March 13, 2027. Each vested unit entitles him to receive one share of GE HealthCare common stock, and settlement may be deferred under the company’s non-employee director compensation plan.

Positive

  • None.

Negative

  • None.
Insider Lobo Kevin
Role Director
Type Security Shares Price Value
Grant/Award Common Stock, par value $0.01 per share 777 $0.00 --
Holdings After Transaction: Common Stock, par value $0.01 per share — 777 shares (Direct)
Footnotes (1)
  1. Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) March 13, 2027. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan. Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Lobo Kevin
(Last) (First) (Middle)
500 WEST MONROE STREET
(Street)
CHICAGO IL 60661
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
GE HealthCare Technologies Inc. [ GEHC ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
03/13/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, par value $0.01 per share 03/13/2026 A 777(1)(2) A $0 777 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 100% will vest on the earlier of: (i) the date of GE HealthCare's next annual meeting of stockholders and (ii) March 13, 2027. Settlement of vested restricted stock units may be deferred by the director, in which case, settlement will occur pursuant to the reporting person's applicable deferral election in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan.
2. Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.
Remarks:
/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact 03/17/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did GEHC director Kevin Lobo report in this Form 4 filing?

Kevin Lobo reported receiving 777 restricted stock units of GE HealthCare common stock as director compensation. The award was granted at no cash cost and increases his directly held equity stake to 777 units, subject to vesting and potential settlement deferral elections.

How many GEHC shares are covered by Kevin Lobo’s new equity award?

The award covers 777 restricted stock units tied to GE HealthCare common stock. Each restricted stock unit represents the right to receive one share upon settlement, so full vesting and settlement would deliver 777 GE HealthCare common shares to the director under the plan terms.

When do Kevin Lobo’s GEHC restricted stock units vest?

All 777 restricted stock units vest in full on the earlier of GE HealthCare’s next annual meeting of stockholders or March 13, 2027. This single vesting date structure links the award directly to his board service during the current director term.

Is Kevin Lobo’s Form 4 transaction a market purchase or sale of GEHC stock?

The filing reports a grant of restricted stock units, not a market trade. The transaction code is “A” for a grant, and the price per share is listed as zero, indicating director equity compensation instead of an open-market purchase or sale of existing shares.

Can settlement of Kevin Lobo’s GEHC restricted stock units be deferred?

Yes. The filing states that settlement of vested restricted stock units may be deferred at the director’s election. If deferred, settlement timing will follow his deferral election under GE HealthCare’s Non-Employee Director Compensation and Benefits Plan, rather than occurring immediately at vesting.

What does each GEHC restricted stock unit granted to Kevin Lobo represent?

Each restricted stock unit represents the right to receive one share of GE HealthCare common stock at settlement. After vesting, the units convert into shares on the settlement date, either immediately or on a deferred schedule elected under the company’s non-employee director compensation program.
Ge Healthcare Technologies Inc

NASDAQ:GEHC

View GEHC Stock Overview →

GEHC Rankings

#426 Ranked by Market Cap
N/A Ranked by Dividends

GEHC Latest News

Mar 31, 2026
GE HealthCare Recommends Shareholders Reject “Mini-Tender” Offer by Potemkin Limited
Mar 26, 2026
GE HealthCare announces lead industrial role in largest EU-funded IHI consortium to advance cardio-oncology care across Europe
Mar 25, 2026
GE HealthCare to showcase comprehensive cardiology portfolio at ACC.26, including its latest AI-enabled imaging technologies, advanced software solutions, and key collaborations
Mar 23, 2026
GE HealthCare’s Photonova Spectra photon-counting CT receives FDA clearance
Mar 18, 2026
GE HealthCare completes Intelerad acquisition – accelerating shift to cloud-first enterprise solutions to deliver precision care

GEHC Latest SEC Filings

Mar 26, 2026
[SCHEDULE 13G/A] GE HealthCare Technologies Inc. Amended Passive Investment Disclosure
Mar 19, 2026
[ARS] GE HealthCare Technologies Inc. SEC Filing
Mar 19, 2026
[DEF 14A] GE HealthCare Technologies Inc. Definitive Proxy Statement
Mar 17, 2026
[Form 3] GE HealthCare Technologies Inc. Initial Statement of Beneficial Ownership
Mar 17, 2026
[8-K] GE HealthCare Technologies Inc. Reports Material Event

GEHC Stock Data

32.48B
454.63M
Medical Devices
X-ray Apparatus & Tubes & Related Irradiation Apparatus
Link
United States
CHICAGO